Pharmaceutical

NHS rolls out “more convenient” Ocrevus injection for multiple sclerosis

The subcutaneous formulation of Roche’s blockbuster Ocrevus will cut hospital treatment time for patients.

Jul 14, 2024 - 04:00
NHS rolls out “more convenient” Ocrevus injection for multiple sclerosis
The subcutaneous formulation of Roche’s blockbuster Ocrevus will cut hospital treatment time for patients.
Read the original article

Tags:

Previous Article

Explainer: Labour has been elected in the UK – now what?

Next Article

Ipsen gains global rights to Foreseen Biotech’s FS001 ADC

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Lawsuit says Cigna illegally denies claims in bulk, sticking patients with unexpected bills

STAT+: Lawsuit says Cigna illegally denies claims in bu...

Jul 24, 2023

FDA grants rare paediatric drug status for IPS HEART’s stem cell drugs

FDA grants rare paediatric drug status for IPS HEART’s ...

Apr 14, 2023

Opinion: Where do we go from here on digital therapeutics?

Opinion: Where do we go from here on digital therapeutics?

Feb 1, 2024